Phospho-MYL6 (Tyr29+Ser30) Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
Myosin is a hexameric ATPase cellular motor protein. It is composed of two heavy chains, two nonphosphorylatable alkali light chains, and two phosphorylatable regulatory light chains. This gene encodes a myosin alkali light chain that is expressed in smooth muscle and non-muscle tissues. Genomic sequences representing several pseudogenes have been described and two transcript variants encoding different isoforms have been identified for this gene.
Synonyms
ESMLC; LC 17; LC17; LC17 GI; LC17 NM; LC17A; LC17B; MLC 3; MLC-3; MLC1SM; MLC3; MLC3NM; MLC3SM; MYL 6; MYL6; MYL6_HUMAN; Myosin light chain 3; Myosin light chain 6 alkali smooth muscle and non muscle; Myosin light chain A3; Myosin light chain alkali 3; Myosin light polypeptide 6 alkali smooth muscle and non muscle; Myosin light polypeptide 6; Smooth muscle and non muscle myosin alkali light chain; Smooth muscle and nonmuscle myosin light chain alkali 6; 17 kDa myosin light chain.
Gene ID
4637
Modification Site
Tyr29+Ser30
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Mouse
Target
Phospho-MYL6 (Tyr29+Ser30)
Clonality
Polyclonal
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic phosphopeptide derived from human MYL6 around the phosphorylation site of Tyr29+Ser30
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Phosphorylation
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
4637
Predicted Cross Reactivity
Human, Rat, Sheep, Pig, Chicken
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RG-A262919-01 10 mg
N- (2- (4-Chlorophenoxy) Ethyl) -7- (Phenylsulfonamido) Heptanamide
Ask
View Details 
RG-A262919-02 25 mg
N- (2- (4-Chlorophenoxy) Ethyl) -7- (Phenylsulfonamido) Heptanamide
Ask
View Details 
RG-A262919-03 50 mg
N- (2- (4-Chlorophenoxy) Ethyl) -7- (Phenylsulfonamido) Heptanamide
Ask
View Details RG-A262919-04 100 mg
N- (2- (4-Chlorophenoxy) Ethyl) -7- (Phenylsulfonamido) Heptanamide
Ask
View Details